BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6590017)

  • 21. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.
    Chevallier B; Heintzmann F; Mosseri V; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M; Asselain B
    Cancer; 1988 Dec; 62(12):2517-24. PubMed ID: 3191451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in steroid receptor status with disease stage in breast cancer.
    Stebbings WS; Anderson E; Puddefoot JR; Vinson GP; Gilmore OJ; Plowman PN
    Eur J Surg Oncol; 1989 Aug; 15(4):322-7. PubMed ID: 2759250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences.
    Ruder AM; Lubin F; Wax Y; Geier A; Alfundary E; Chetrit A
    Cancer; 1989 Jul; 64(1):196-202. PubMed ID: 2731116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors].
    Reiner G; Jakesz R; Kolb R; Kühnl-Brady K; Reiner A; Schemper M; Spona J
    Dtsch Med Wochenschr; 1988 Jun; 113(22):892-7. PubMed ID: 3371221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of estrogen and progesterone receptors to prognosis in breast cancer.
    Gelbfish GA; Davidson AL; Kopel S; Schreibman B; Gelbfish JS; Degenshein GA; Herz BL; Cunningham JN
    Ann Surg; 1988 Jan; 207(1):75-9. PubMed ID: 3337566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
    Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.
    Clark GM; Osborne CK; McGuire WL
    J Clin Oncol; 1984 Oct; 2(10):1102-9. PubMed ID: 6491696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone receptors and human breast cancer.
    Clark GM; McGuire WL
    Breast Cancer Res Treat; 1983; 3(2):157-63. PubMed ID: 6351950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychosocial correlates of oestrogen and progesterone receptors in breast cancer.
    Razavi D; Farvacques C; Delvaux N; Beffort T; Paesmans M; Leclercq G; Van Houtte P; Paridaens R
    Lancet; 1990 Apr; 335(8695):931-3. PubMed ID: 1970025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
    Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic value of hormone receptor in breast cancer].
    Yamamoto H; Morimoto T; Komaki K; Inui K; Ohshimo K; Tanaka T; Monden Y
    Nihon Geka Gakkai Zasshi; 1987 Jan; 88(1):96-101. PubMed ID: 3821719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
    Kuukasjärvi T; Kononen J; Helin H; Holli K; Isola J
    J Clin Oncol; 1996 Sep; 14(9):2584-9. PubMed ID: 8823339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone receptors as a prognostic factor in Stage II breast cancer.
    Clark GM; McGuire WL; Hubay CA; Pearson OH; Marshall JS
    N Engl J Med; 1983 Dec; 309(22):1343-7. PubMed ID: 6633596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone.
    Campbell EJ; Tesson M; Doogan F; Mohammed ZMA; Mallon E; Edwards J
    Br J Cancer; 2016 Oct; 115(8):967-973. PubMed ID: 27657341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormone receptors (ER, PgR) as a prognostic factor in breast cancer].
    Kimura M; Koida T; Shimizu Y; Fukuda T; Sakaue S; Nakamura S
    Gan No Rinsho; 1988 Aug; 34(9):1083-8. PubMed ID: 3172513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oestrogen receptors revisited: long-term follow up of over five thousand breast cancer patients.
    Hähnel R; Spilsbury K
    ANZ J Surg; 2004 Nov; 74(11):957-60. PubMed ID: 15550082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term study of the significance of hormone receptors as prognostic factors in breast cancer].
    Merkle E; Seidl I; Bähr I; Tulusan AH; von Maillot K; Sauerbrei KW; Wirtz PM
    Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):528-32. PubMed ID: 2391019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of steroid hormone receptor analysis in predicting time to treatment failure in operable breast cancer.
    Klein B; Falkson G; Terblanche AP; Klein T; Potgieter HC; Smit CF
    S Afr Med J; 1986 Mar; 69(5):283-6. PubMed ID: 3961607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].
    Chevallier B; Heintzman F; Asselain B; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M
    Bull Cancer; 1988; 75(1):23-36. PubMed ID: 3359056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Steroid hormone receptors in breast cancer].
    Nomura Y
    Rinsho Byori; 1990 Jan; 38(1):26-30. PubMed ID: 2308219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.